Maynard Ryan D (CIK 0001363984)

Latest company ownership

Shares held
100,000
Last filed at
Nov 7, 2017
Confidence Score
50.0
2025Q4
Confidence Score History
2012Q3 2025Q4
Shares held
50,000
Last filed at
Nov 14, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2022Q2 2025Q4
Shares held
8,012
Last filed at
Feb 12, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 12, 2024 Nov 14, 2024 IOVANCE BIOTHERAPEUTICS, INC. Director Sell 20.0 -50,000 -86.96% ✗ $503K
Feb 8, 2023 Feb 12, 2024 Tvardi Therapeutics, Inc. CFO Sell 15.0 -5,488 -40.65% ✓ $2.9K
May 31, 2022 Jun 2, 2022 IOVANCE BIOTHERAPEUTICS, INC. Director Buy 95.0 +7,500 100.00% ✗ $50.6K
Nov 3, 2017 Nov 7, 2017 RIGEL PHARMACEUTICALS INC CFO Sell 7.5 -100,000 -100.00% ✓ $390K
Sep 12, 2012 Sep 14, 2012 RIGEL PHARMACEUTICALS INC CFO Sell 22.5 -23,302 -100.00% ✗ $248.6K
Sep 7, 2012 Sep 14, 2012 RIGEL PHARMACEUTICALS INC CFO Sell 22.5 -23,302 -100.00% ✗ $248.6K
Sep 7, 2012 Sep 11, 2012 RIGEL PHARMACEUTICALS INC CFO Sell 20.0 -51,698 -100.00% ✗ $544.9K
Aug 7, 2012 Aug 9, 2012 RIGEL PHARMACEUTICALS INC CFO Sell 26.3 -1,700 -100.00% ✗ $18K